Imperial Brands Expects Net Revenue Growth in Low Single Digits

Apr.14.2023
Imperial Brands Expects Net Revenue Growth in Low Single Digits
Tobacco and e-cigarette manufacturer Imperial Brands expects low net revenue growth and increased profit within three years.

On April 13th, tobacco and e-cigarette manufacturer Imperial Brands announced that it is steadily working towards meeting its full-year expectations and anticipates achieving low single-digit net revenue growth. Over the next three years, the company expects its operating profit growth to accelerate, reaching a median compound annual growth rate.


The announcement highlights its main core features in five key points.


The company maintained a strong market share and stable tobacco pricing in five major combustible tobacco markets. The launch of new products such as e-cigarettes, heated tobacco, and modern oral products also contributed to the growth of net income. Despite the impact of COVID-19, the group's adjusted operating profit in the first half of the year remained unchanged from the same period last year, reflecting the effects of COVID-19 on cigarette sales, increased investment in new products, and the impact of exiting the Russian market last year. The company is expected to achieve revenue and profit growth in line with expectations and guidance for the full year. They have completed £523 million of their £1 billion share buyback program for the fiscal year 2023, which represents approximately 2.7% of the issued share capital.


Combustible tobacco market.


Imperial Tobacco is predicting that their market share in the five major markets will remain steady or increase compared to the same period last year in the first half of this year. Although their market share in Germany and the UK is expected to decline, the market share in the US, Spain, and Australia is expected to remain stable or grow, offsetting the decline in those two countries. The company has maintained a strict pricing system in these five major markets.


New tobacco market.


Imperial Tobacco has made progress in the development and launch of new tobacco products. In the e-cigarette market, they have introduced the blu 2.0 product in the UK, Spain, France, Czech Republic, and Portugal.


Due to the strong growth in Europe, it is expected that revenue from new tobacco products will exceed that of the same period last year in the first half of the year. This is enough to offset the decline caused by the uncertainty from the US marketing ban.


Central and Eastern Europe have been integrated into the AAA region, creating the AAACE region.


Imperial Tobacco is transferring the management of its Central and Eastern Europe (CEE) cluster from Europe to the African, Asian, and Australian (AAA) region. The AAA region will now be referred to as AAACE.


The markets that have been affected by the transfer of regional management this time include Poland, the Czech Republic, Ukraine, Slovakia, Hungary, Azerbaijan, Armenia, Georgia, Moldova, Croatia, and Slovenia.


In the half-year restatement report ending on March 31, 2023, Imperial Tobacco reported a total revenue of £1.37 billion in the New Europe region and £965 million in the AAACE region.


The primary source of revenue for the new tobacco industry is Europe. The revenue generated by the new tobacco industry in the New Europe region is worth £74 million, while the Old Europe region generates £77 million worth of revenue. The new tobacco industry in Europe accounts for 5.4% of total revenue.


Note: The original amount of 1.569 billion pounds for Europe minus 199 million pounds for the Central and Eastern European (CEE) region equals the new amount of 1.37 billion pounds for the expanded European region.


The total amount of 965 million pounds was obtained by combining 766 million pounds from the AAA region and 199 million pounds from the CEE region in the AAACE region.


Imperial Brands PLC has published a report according to an announcement made by the company.


The mid-year performance report covering the period ending March 31, 2023, will be released to the public on May 16, 2023.


Reference:


Imperial Brands is expected to meet full-year guidance based on the pre-close trading update.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
BAT CFO Dragos Constantinescu Takes Office, Returning After Seven Years and Former Asahi Europe Leadership Role
BAT CFO Dragos Constantinescu Takes Office, Returning After Seven Years and Former Asahi Europe Leadership Role
Dragos Constantinescu has officially taken up his role as Chief Financial Officer and Executive Director at British American Tobacco (BAT). He previously spent 16 years at BAT across finance and general management roles in Europe before joining Asahi in 2019 and becoming CEO of Asahi Europe & International in 2025. His return comes as BAT continues to advance its “A Better Tomorrow” transformation.
BAT
Sep.01
Philippines Customs Seizes PHP11.68 Billion($200 Million) in Illegal Tobacco and Vapes in First Seven Months of 2026
Philippines Customs Seizes PHP11.68 Billion($200 Million) in Illegal Tobacco and Vapes in First Seven Months of 2026
Philippines Customs data showed that illegal cigarettes and vape products seized during the first seven months of 2026 were valued at about PHP11.68 billion, exceeding the PHP2.516 billion recorded for the full year of 2025. The figures were disclosed by a Bureau of Customs official during a House Committee on Ways and Means hearing on tobacco excise tax reforms. Vape-related seizures were valued at about PHP1.65 billion, with most cases recorded at the Manila International Container Port. Customs officials said enforcement against illicit tobacco trade would continue.
Aug.26
Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Philip Morris Japan (PMJ) launched TEREA Black Mint Pearl on October 15, 2026, introducing the first capsule-equipped heated tobacco stick in the TEREA Black range for IQOS ILUMA devices. The product combines a strong menthol profile with a crushable mint capsule and is priced at ¥640 per 20-stick pack, including tax. Sales began at four IQOS stores and selected retail partners on October 15, with distribution expanding to convenience stores and other tobacco retailers nationwide from October 19. The launch brings Japan's TEREA portfolio to 28 variants, including 21 menthol-related products, or 75% of the range.
product
Oct.16 by 2Firsts Perspectives
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Japan Tobacco (JT) will launch MEVIUS Tropical Option, a new tobacco stick for Ploom, nationwide in Japan from October 6, 2026. The capsule-format product combines mango-oriented sweetness with menthol cooling, adding a tropical flavor to the MEVIUS Ploom tobacco-stick lineup for the first time. Each pack contains 20 sticks and will launch at JPY 590. The product is compatible with all Ploom devices, and its addition will expand the Ploom tobacco-stick portfolio to 32 variants.
Sep.08